{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:45:27Z","timestamp":1791377127428,"version":"4.3.2"},"reference-count":26,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/501100009233","name":"Majlis Amanah Rakyat","doi-asserted-by":"publisher","award":["327587 PGR N Binti Supari"],"award-info":[{"award-number":["327587 PGR N Binti Supari"]}],"id":[{"id":"10.13039\/501100009233","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2026,1,26]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The availability of large volumes of data from genetic testing has enabled the interpretation of more DNA variants, contributing to a greater number of identified variants of uncertain significance (VUS). The growing number of VUS causes a burden of inconclusive findings in clinical practice. Osteogenesis imperfecta (OI) is a genetically heterogeneous connective tissue disorder causing bone fragility and limb deformity. Pathogenic variants in two collagen genes,\n                      <jats:italic>COL1A1<\/jats:italic>\n                      and\n                      <jats:italic>COL1A2,<\/jats:italic>\n                      account for around 90% of all OI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Data mining of the variants from Sheffield Diagnostic Genetics Service, the national OI testing hub (UK), was conducted to collate all VUS in\n                      <jats:italic>COL1A1<\/jats:italic>\n                      and\n                      <jats:italic>COL1A2<\/jats:italic>\n                      identified. All VUS were then reclassified according to the latest 2024 ACGS (Association for Clinical Genomic Science) best practice guidelines.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 161 VUS in\n                      <jats:italic>COL1A1<\/jats:italic>\n                      and 98 VUS in\n                      <jats:italic>COL1A2<\/jats:italic>\n                      were identified and reanalysed. For\n                      <jats:italic>COL1A1<\/jats:italic>\n                      , we found that 2% VUS were upgraded to likely pathogenic (LP), 23% of the VUS were downgraded to likely benign and benign, 12% were reclassified as hot VUS and the remaining 63% have not changed classification as VUS. With regard to\n                      <jats:italic>COL1A2<\/jats:italic>\n                      , only 1% of the VUS were upgraded to LP, 25% were downgraded to likely benign and benign, 13% were reclassified as hot VUS and 61% remained as VUS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>From this study, we demonstrated that iterative reanalysis of VUS is crucial in clinical practice as new data and evidence become available. This dynamic process will significantly improve diagnostic accuracy and inform patient care decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jmg-2025-111334","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:21:35Z","timestamp":1770747695000},"page":"277-283","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Reclassification of variants of uncertain significance in type I collagen genes: a national reference laboratory experience"],"prefix":"10.1136","volume":"63","author":[{"given":"Nurhaziqah","family":"Supari","sequence":"first","affiliation":[{"name":"Division of Clinical Medicine, The University of Sheffield School of Medicine and Population Health, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Baker","sequence":"additional","affiliation":[{"name":"Connective Tissue Disorders Service, Sheffield Diagnostic Genetics Service, Sheffield Children\u2019s Hospital, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8366-9655","authenticated-orcid":false,"given":"Sylvia","family":"Keigwin","sequence":"additional","affiliation":[{"name":"Connective Tissue Disorders Service, Sheffield Diagnostic Genetics Service, Sheffield Children\u2019s Hospital, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Delaney","sequence":"additional","affiliation":[{"name":"Connective Tissue Disorders Service, Sheffield Diagnostic Genetics Service, Sheffield Children\u2019s Hospital, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Makino","sequence":"additional","affiliation":[{"name":"Connective Tissue Disorders Service, Sheffield Diagnostic Genetics Service, Sheffield Children\u2019s Hospital, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1488-3695","authenticated-orcid":false,"given":"Meena","family":"Balasubramanian","sequence":"additional","affiliation":[{"name":"Division of Clinical Medicine, The University of Sheffield School of Medicine and Population Health, Sheffield, UK"},{"name":"Sheffield Clinical Genomics Service, The University of Sheffield, Sheffield, UK"},{"name":"Sheffield Children\u2019s NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"2026042009000688000_63.5.277.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.04.018"},{"key":"2026042009000688000_63.5.277.2","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-8-78","article-title":"Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta\/Ehlers-Danlos Syndrome overlap syndrome","volume":"8","author":"Malfait","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"2026042009000688000_63.5.277.3","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddn374"},{"key":"2026042009000688000_63.5.277.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2010.01.034"},{"key":"2026042009000688000_63.5.277.5","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11920","article-title":"MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfecta","volume":"7","author":"Lindert","year":"2016","journal-title":"Nat Commun"},{"key":"2026042009000688000_63.5.277.6","doi-asserted-by":"publisher","DOI":"10.1093\/jlb\/lsx038"},{"key":"2026042009000688000_63.5.277.7","doi-asserted-by":"publisher","DOI":"10.7326\/M21-4109"},{"key":"2026042009000688000_63.5.277.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.05.002"},{"key":"2026042009000688000_63.5.277.9","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2024-110228"},{"key":"2026042009000688000_63.5.277.10","unstructured":"Durkie M , Cassidy E-J , Berry I , et al . ACGS best practice guidelines for variant classification in rare disease 2024. 2024."},{"key":"2026042009000688000_63.5.277.11","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1090"},{"key":"2026042009000688000_63.5.277.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-020-02199-3"},{"key":"2026042009000688000_63.5.277.13","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2026042009000688000_63.5.277.14","unstructured":"Ellard S , Baple EL , Callaway A , et al . ACGS best practice guidelines for variant classification in rare disease 2020. 2020."},{"key":"2026042009000688000_63.5.277.15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s10038-025-01348-8","article-title":"Reclassification of variants of uncertain significance in neonatal genetic diseases: implications from a clinician\u2019s perspective","volume":"70","author":"Wu","year":"2025","journal-title":"J Hum Genet"},{"key":"2026042009000688000_63.5.277.16","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2023-109488"},{"key":"2026042009000688000_63.5.277.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2023.06.002"},{"key":"2026042009000688000_63.5.277.18","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1675","article-title":"Genetic analysis in Japanese patients with osteogenesis imperfecta: Genotype and phenotype spectra in 96 probands","volume":"9","author":"Higuchi","year":"2021","journal-title":"Mol Genet Genomic Med"},{"key":"2026042009000688000_63.5.277.19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/CM9.0000000000000013","article-title":"Genotype-phenotype relationship in a large cohort of osteogenesis imperfecta patients with COL1A1 mutations revealed by a new scoring system","volume":"132","author":"Li","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"2026042009000688000_63.5.277.20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40618-023-02123-2","article-title":"Genotype-phenotype relationship and comparison between eastern and western patients with osteogenesis imperfecta","volume":"47","author":"Lin","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"2026042009000688000_63.5.277.21","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22677"},{"key":"2026042009000688000_63.5.277.22","doi-asserted-by":"publisher","DOI":"10.1002\/HUMU.24309"},{"key":"2026042009000688000_63.5.277.23","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1007\/s00198-016-3709-1","article-title":"DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum","volume":"27","author":"Bardai","year":"2016","journal-title":"Osteoporos Int"},{"key":"2026042009000688000_63.5.277.24","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20429"},{"key":"2026042009000688000_63.5.277.25","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.amjsurg.2018.08.008","article-title":"Factors predicting reclassification of variants of unknown significance","volume":"216","author":"Wright","year":"2018","journal-title":"Am J Surg"},{"key":"2026042009000688000_63.5.277.26","doi-asserted-by":"crossref","first-page":"100801","DOI":"10.1016\/j.gim.2023.100801","article-title":"Practical considerations for reinterpretation of individual genetic variants","volume":"25","author":"Appelbaum","year":"2023","journal-title":"Genet Med"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2025-111334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:00:16Z","timestamp":1776700816000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2025-111334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,4,20]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/jmg-2025-111334"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2025-111334","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}